Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Elevated Levels of Cytokines and Chemokines in Patients with Antiphospholipid (aPL) Antibodies.

Silvia S Pierangeli, Ph.D., Laura Aline Martinez-Martinez, Renan Aguilar-Valenzuela, Gerald Mc Gwin, Ellis Doan, Elizabeth Papalardo, Jo Ann Vega, Emilio B. Gonzalez, Vijaya Murthy, Alan SEif, Doruk Erkan

Blood (2009) 114 (22): 5062.

https://doi.org/10.1182/blood.V114.22.5062.5062

Published: 2009

Journal Articles

Statins Reduce Disease Activity (SLAM-R) and Organ Damage Accrual (SLICC Damage Index, SDI) Scores in SLE Patients From A Multi-Center, Multi-Ethnic, US Cohort.

Silvia S Pierangeli, Ph.D., Alan SEif, Renan Aguilar-Valenzuela, Laura Aline Martinez-Martinez, Ellis Doan, Neha Dang, Elizabeth Papalardo, John D. Reveille, Graciela S. Alarcon

Blood (2009) 114 (22): 5066.

https://doi.org/10.1182/blood.V114.22.5066.5066

Published: 2009

Journal Articles

C6-Deficient Mice Are Protected From the Pathogenic Effects of Antiphospholipid Antibodies.

Ana Laura Carrera-Marin, Zurina Romay-Penabad, Ph.D., Renan Aguilar-Valenzuela, Laura Aline Martinez-Martinez, Elizabeth Papalardo, Silvia S Pierangeli, Ph.D.

Blood (2009) 114 (22): 147.

https://doi.org/10.1182/blood.V114.22.147.147

Published: 2009

Journal Articles

Apolipoprotein E Receptor 2′ Mediates Pathogenic Effects of Dimeric β 2 glycoprotein I and of Anti- β 2 glycoprotein I Antibodies in Vivo

Zurina Romay-Penabad, Ph.D., Rolf T Urbanus, MD, Elizabeth Pappalardo, B.S., Yong Hwang, M.D., Ronald H.W.M. Derksen, MD., Tuya Shilagard, Ph.D., Gracie Vargas, Ph.D., Maarten TT Pennings, Ph.D., Philip G De Groot, PhD, Silvia S Pierangeli, Ph.D.

Blood (2008) 112 (11): 408.

https://doi.org/10.1182/blood.V112.11.408.408

Published: 2008

Journal Articles

Annexin A2 Deficient Mice Are Resistant to Pathogenic Effects of Antiphospholipid Antibodies in Vivo

Zurina Romay-Penabad, Ph.D., Guadalupe Montiel-Manzano, M.S., Elizabeth Pappalardo, B.S., Katherine A. Hajjar, MD, Tuya Shilagard, Ph.D., Gracie Vargas, Ph.D., Silvia S Pierangeli, Ph.D.

Blood (2008) 112 (11): 421.

https://doi.org/10.1182/blood.V112.11.421.421

Published: 2008

NARROW

Elevated Levels of Cytokines and Chemokines in Patients with Antiphospholipid (aPL) Antibodies.

Statins Reduce Disease Activity (SLAM-R) and Organ Damage Accrual (SLICC Damage Index, SDI) Scores in SLE Patients From A Multi-Center, Multi-Ethnic, US Cohort.

C6-Deficient Mice Are Protected From the Pathogenic Effects of Antiphospholipid Antibodies.

Apolipoprotein E Receptor 2′ Mediates Pathogenic Effects of Dimeric β 2 glycoprotein I and of Anti- β 2 glycoprotein I Antibodies in Vivo

Annexin A2 Deficient Mice Are Resistant to Pathogenic Effects of Antiphospholipid Antibodies in Vivo

Email alerts

ASH Publications

American Society of Hematology

Elevated Levels of Cytokines and Chemokines in Patients with Antiphospholipid (aPL) Antibodies.

Statins Reduce Disease Activity (SLAM-R) and Organ Damage Accrual (SLICC Damage Index, SDI) Scores in SLE Patients From A Multi-Center, Multi-Ethnic, US Cohort.

C6-Deficient Mice Are Protected From the Pathogenic Effects of Antiphospholipid Antibodies.

Apolipoprotein E Receptor 2′ Mediates Pathogenic Effects of Dimeric β 2 glycoprotein I and of Anti- β 2 glycoprotein I Antibodies in Vivo

Annexin A2 Deficient Mice Are Resistant to Pathogenic Effects of Antiphospholipid Antibodies in Vivo

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only